Better Drug Discovery with BRONCH

  • Currently costs $1 billion for every new drug which is approved for market.
  • Pharmaceutical companies rely heavily on animals (often rodents) to test efficacy and safety of potential drugs.
  • Many chemicals which show promise in animal studies fail to work in human trials – these “false starts” increase the cost of drug development.
  • We may also miss potentially useful drugs because they fail to work in rodents.
  • Tissue engineering is the growth of functional organs from human cells in the laboratory.
  • Engineered tissue allows us to test potential drugs in a functional human organ.
  • Testing drugs in human organs will increase the efficiency of drug development by ensuring drugs work in the target organ before human clinical trials.
  • Engineered human organs will reduce the need for animal testing.



© 2011 Bioairway Research Offering New Concepts in Health (BRONCH)

funded by the National Sanitarium Association